Institutional Investors Sentiment Indicator of Ibio Inc (NYSEMKT:IBIO) Falls in 2016 Q4

June 20, 2017 - By Nellie Frank

 Institutional Investors Sentiment Indicator of Ibio Inc (NYSEMKT:IBIO)  Falls in  2016 Q4

Sentiment for Ibio Inc (NYSEMKT:IBIO)

Ibio Inc (NYSEMKT:IBIO) institutional sentiment decreased to 0.6 in Q4 2016. Its down -0.20, from 0.8 in 2016Q3. The ratio is negative, as 3 institutional investors started new or increased equity positions, while 5 reduced and sold their stock positions in Ibio Inc. The institutional investors in our partner’s database now have: 2.83 million shares, down from 2.98 million shares in 2016Q3. Also, the number of institutional investors holding Ibio Inc in their top 10 equity positions was flat from 0 to 0 for the same number . Sold All: 2 Reduced: 3 Increased: 3 New Position: 0.

iBio, Inc. is a biotechnology company. The company has market cap of $32.96 million. The Firm is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. It currently has negative earnings. The Company’s technologies include iBioLaunch technology and iBioModulator.

The stock increased 5.56% or $0.02 on June 19, reaching $0.38. About shares traded. Ibio Inc (NYSEMKT:IBIO) has declined 45.59% since June 20, 2016 and is downtrending. It has underperformed by 62.29% the S&P500.

Signaturefd Llc holds 0.01% of its portfolio in Ibio Inc for 152,910 shares. Bank Of America Corp De owns 2 shares or 0% of their US portfolio. Moreover, Bank Of New York Mellon Corp has 0% invested in the company for 69,463 shares. The Delaware-based Blackrock Advisors Llc has invested 0% in the stock. Blackrock Fund Advisors, a California-based fund reported 21,982 shares.#img1#

More notable recent Ibio Inc (NYSEMKT:IBIO) news were published by: Streetinsider.com which released: “iBio, Inc. (IBIO) Receives Favorable Court Ruling in Fraunhofer USA Litigation” on August 04, 2016, also Streetinsider.com with their article: “iBio, Inc. (IBIO) Arranges Production of IBIO-CFB03 With Caliber Biotherapeutics” published on April 27, 2015, Prnewswire.com published: “iBio, Inc. and GE Healthcare form new global alliance” on July 26, 2012. More interesting news about Ibio Inc (NYSEMKT:IBIO) were released by: Marketwired.com and their article: “iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting” published on May 04, 2017 as well as Marketwired.com‘s news article titled: “iBio Expands Commercial Collaboration With Bio-Manguinhos and Fraunhofer” with publication date: June 17, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.